Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Rang in Aktien #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Aktienkurs
$0.106
Zuletzt synchronisiert: 2026-10-01
Marktkapitalisierung
$767.67K
Veränderung (1 Tag)
73.77%
Veränderung (1 Jahr)
-84.81%
Land
US
Handel Mosaic ImmunoEngineering Inc. (CPMV)

Kategorie

Kursverlauf für Mosaic ImmunoEngineering Inc. (CPMV)
Höchster Schlusskurs: $0.11 am 2026-10-01

Niedrigster Schlusskurs: $63.26 am 2013-01-01
Kursverlauf der Aktie von Mosaic ImmunoEngineering Inc. von 2013 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 24.62%
2025 -50.91%
2024 62.14%
2023 -51.68%
2022 11.87%
2021 -71.75%
2020 215.44%
2019 -50.44%
2018 -23.68%
2017 52.41%
2016 -27.31%
2015 -82.70%
2014 -69.74%
2013 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$504.13 25.00%
US
$190.20 567.62%
US
$123.33 -10.10%
AU
$918.18 14.77%
NL
$736.38 5.83%
CH